Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 4, 1997, Pages 287-295

  Troke, P F ^a   Graninger, W ^b   Meunier, F ^b   Clumeck, N ^b   Dupont, B ^b   Dellamonica, P ^b   Nitenberg, G ^b   Gentilini, M ^b   Frottier, J ^b   Carlet, J ^b   Vachon, F ^b   Rozenbaum, W ^b   Vilde, J L ^b   Acar, J F ^b   Kreis, H ^b   Coulaud, J P ^b   Carbon, C ^b   Hellriegel, K P ^b   Holzmann, F ^b   Ehninger, G ^b   Milatovic, D ^b   Schumacher, K ^b   Stille, W ^b   Kolb, H J ^b   Kujath, P ^b   Drobnic, L ^b   Verger Garau, G ^b   Baquero, F ^b   Gil Aguado, A ^b   Linglof, T ^b   Lindberg, J ^b   Cronberg, S ^b   Clara, F ^b   Hay, R J ^b   Cohen, J ^b   Grant Prentice, H ^b   Newland, A C ^b   Goldstone, A H ^b   Gueret Wardle, D F ^b   more..

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANDIDIASIS; CHOLESTATIC HEPATITIS; CLINICAL TRIAL; CRYPTOCOCCOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; FEMALE; FUNGAL MENINGITIS; FUNGEMIA; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; ORAL DRUG ADMINISTRATION; OROPHARYNX; PERITONITIS; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 8244231268     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01695633     Document Type: Article

References (59)

1. Denning DW: Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement B: 1-16.
2. Pfaller M, Wenzel R: Impact of the changing epidemiology of fungal infections in the 1990s. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 287-291.
3. Richardson MD: Opportunistic and pathogenic fungi. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement A: 1-11.
4. Schaberg DR, Culver DH, Gaynes RP: Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 1991, 91, Supplement 3B: 72-75.
5. Milatovic D, Voss A: Efficacy of fluconazole in the treatment of systemic fungal infections. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11, 395-402.
6. Hay RJ: Overview of the treatment of disseminated fungal infections. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement B: 17-25.
7. Diamond RD: The growing problem of mycoses in patients infected with the human immunodeficiency virus. Reviews of Infectious Diseases 1991, 13: 480-486.
8. Perfect JR, Pickard WW, Hunt DL, Palmer B, Schell WA: The use of amphotericin B in nosocomial fungal infection. Reviews of Infectious Diseases 1991, 13: 474-479.
9. Meunier F: Fluconazole treatment of fungal infections in the immunocompromised host. Seminars in Oncology 1990, 17, Supplement 6: 19-23.
10. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ: Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 1986, 104: 234-240.
11. Hay RJ: Antifungal therapy and the new azole compounds. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement A: 35-46.
12. Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAuliffe VJ, Follansbee SE, Tuazon CU, Stern JJ, Feinberg J, Hafner R, Dismukes WE, the NIAID AIDS Clinical Trials Group, and the NIAID Mycoses Study Group: A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 1992, 326: 793-798.
13. Powderly WG: Therapy for cryptococcal meningitis in patients with AIDS. Clinical Infectious Diseases 1992, 14, Supplement 1: 54-59.
14. Humphrey MJ, Jevons S, Tarbit MH: Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrobial Agents and Chemotherapy 1985, 28: 648-653.
15. Arndt CAS, Walsh TJ, McCully CL, Balis FM, Pizzo PA, Poplack DG: Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. Journal of Infectious Diseases 1988, 157: 178-180.
16. Brammer KW, Farrow PR, Faulkner JK: Pharmacokinetics and tissue penetration of fluconazole in humans. Reviews of Infectious Diseases 1990, 12, Supplement 3: 318-326.
17. Pasko MT, Piscitelli SC, Van Slooten AD: Fluconazole: a new triazole antifungal agent. DICP Annals of Pharmacotherapy 1990, 24: 860-867.
18. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE, the NIAID Mycoses Study Group, and the AIDS Clinical Trials Group: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. New England Journal of Medicine 1992, 326: 83-89.
19. Larsen RA, Leal MAE, Chan LS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Annals of Internal Medicine 1990, 113: 183-187.
20. Kujath P, Lerch K, Kochendörfer P, Boos C: Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993, 6: 376-382.
21. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheid WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD for the Candidemia Study Group and the NIAID Mycoses Study Group: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New England Journal of Medicine 1994, 331: 1325-1330.
22. Cohen J: Treatment of systemic yeast infection with fluconazole. Journal of Antimicrobial Chemotherapy 1989, 23: 294-295.
23. Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A: Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. American Journal of Medicine 1991, 91: 142-150.
24. Ikemoto H: A clinical study of fluconazole for the treatment of deep mycoses. Diagnostic Microbiology and Infectious Diseases 1989, 12: 239S-247S.
25. Kauffman CA, Bradley SF, Ross SC, Weber DR: Hepatosplenic candidiasis: successful treatment with fluconazole. American Journal of Medicine 1991, 91: 137-141.
26. Bren A, Kandus A, Lindi J, Varl J: Fluconazole in the treatment of fungal infections in kidney-transplanted patients. Transplantation Proceedings 1992, 24: 2765-2766.
27. Diaz M, Negroni R, Montero-Gei F, Castro LGM, Sampaio SAP, Borelli D, Restrepo A, Franco L, Bran JL, Arathoon EG, Stevens DA, and other investigators of the Fluconazole Pan-American Study Group: A pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clinical Infectious Diseases 1992, 14, Supplement 1: 68-76.
28. Robinson PA, Knirsch AK, Joseph JA: Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Reviews of Infectious Diseases 1990, 12, Supplement 3: 349-363.
29. Van't Wout JW, Mattie H, van Furth R: A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. Journal of Antimicrobial Chemotherapy 1988, 21: 665-672.
30. Nolla-Salas J, Leon C, Torres-Rodriguez JM, Martin E, Sitges-Serra A: Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clinical Infectious Diseases 1992, 14: 952-954.
31. Catanzaro A, Galgiani JN, Levine BE, Sharkey-Mathis PK, Fierer J, Stevens DA, Chapman SW, Cloud G, and the NIAID Mycoses Study Group: Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidiomycosis. American Journal of Medicine 1995, 98: 249-256.
32. Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, Graybill JR, and the NIAID Mycoses Study Group: Fluconazole therapy for coccidioidal meningitis. Annals of Internal Medicine 1993, 119: 28-35.
33. Graninger W, Prester E, Schneeweiss B, Teleky B, Georgopoulos A: Treatment of Candida albicans fungaemia with fluconazole. Journal of Infection 1993, 26: 133-146.
34. Haubrich RH, Haghighat D, Bozzette SA, Tilles J, McCutchan JA, and the California Collaborative Treatment Group: High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. Journal of Infectious Diseases 1994, 170: 238-242.
35. Pappas PG, Bradsher RW, Chapman SW, Kauffman CA, Dine A, Cloud GA, Dismukes WE, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group: Treatment of blastomycoses with fluconazole: a pilot study. Clinical Infectious Diseases 1995, 20: 267-271.
36. Presterl E, Graninger W, and a Multicentre Study Group: Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 347-351.
37. Bridge KS, Goodpasture HC: Disseminated histoplasmosis treated with fluconazole. Kansas Medicine 1994, 95: 113-115.
38. Czwerwiec FS, Busker MS, Kamerman ML, Bisno AL: Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis. American Journal of Medicine 1993, 94: 545-546.
39. Kostiuk KA, Pons VG, Guglielmo BJ: Penetration of fluconazole into abscess fluid. Journal of Antimicrobial Chemotherapy 1994, 34: 603-605.
40. Krcmery V, Jr, Trupl J, Krídl J, Danišovicová A: Renal abscess and fungaemia due to Torulopsis glabrata: successful treatment with drainage and fluconazole. Clinical Infectious Diseases 1994, 18: 116.
41. Levine J, Bernard DB, Idelson BA, Saunders C, Sugar AM: Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. American Journal of Medicine 1989, 86: 825-827.
42. Simsek Ü, Akinci H, Oktay B, Kavrama I, Özyurt M: Treatment of catheter-associated candiduria with fluconazole irrigation. British Journal of Urology 1995, 75: 75-77.
43. Sugar AM, Saunders C, Diamond RD: Successful treatment of Candida osteomyelitis with fluconazole. Diagnostic Microbiology and Infectious Diseases 1990, 13: 517-520.
44. Schwartz DN, Fihn SD, Miller RA: Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. Clinical Infectious Diseases 1993, 16: 486-488.
45. Tacker JR: Successful use of fluconazole for treatment of urinary tract fungal infections. Journal of Urology 1992, 148: 1917-1918.
46. Tang C: Successful treatment of Candida albicans osteomyelitis with fluconazole. Journal of Infection 1993, 26: 89-92.
47. Thakur RK, Skelcy KM, Kahn RN, Cannon L, Cherukuri R: Successful treatment of Candida prosthetic valve endocarditis with a combination of fluconazole and amphotericin B. Critical Care Medicine 1994, 22: 712-714.
48. Tunkel AR, Thomas CY, Wispelwey B: Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. American Journal of Medicine 1993, 94: 100-103.
49. Türker A, Altinörs N, Aciduman A, Demiralp O, Uluoglu U: MRI findings and encouraging fluconazole treatment results of intracranial Cladosporium trichoides infection. Infection 1995, 23: 60-62.
50. Urbak SF, Degn T: Fluconazole in the management of fungal ocular infections. Ophthalmologica 1994, 208: 147-156.
51. Luttrull JK, Wan WL, Kubak BM, Smith MD, Oster HA: Treatment of ocular fungal infections with oral fluconazole. American Journal of Ophthalmology 1995, 119: 477-481.
52. Nightingale SD: Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole. Archives of Internal Medicine 1995, 155: 538-540.
53. Bennett JE: Antifungal agents. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 361-370.
54. National Institute of Allergy and Infectious Disease Mycoses Study Group: Treatment of blastomycosis and histoplasmosis with ketoconazole. Annals of Internal Medicine 1985, 103: 861-872.
55. Denning DW, Tucker RM, Hanson LH, Stevens DA: Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine 1989, 86: 791-800.
56. Phillips P, Fetchick R, Weisman I, Foshee S, Graybill JR: Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results. Reviews of Infectious Diseases 1987, 9, Supplement 1: 87-93.
57. De Wit S, Goossens H, Weerts D, Clumeck N: Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989, 1: 746-748.
58. Laine L, Dretler RH, Conteas CN, Tuazon C, Koster FM, Sattler F, Squires K, Islam MZ: Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. Annals of Internal Medicine 1992, 117: 655-660.
59. Meunier F, Aoun M, Gerard M: Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Reviews of Infectious Diseases 1990, 12, Supplement 3: 364-368.